Teva Pharmaceutical Industries Limited
- Jurisdiction
Israel - LEI
549300BAFGM4RC74ZJ94 - ISIN
IL0006290147 (TEVA.TA )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. Read full profile
Fundamentals
- Net revenue
€14.18B - Gross margin
49.6% - EBIT
€762.54M - EBIT margin
5.4% - Net income
-€134.77M - Net margin
-1.0%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
| N/A |
Stock price
Dividends
- Last dividend amount
-
ILA 8.50 - Ex date
-
- Payment date
-
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Stanley Druckenmiller |
|
|
|
Buy |
| Andreas Halvorsen |
|
|
|
Buy |
| Peter Brown |
|
|
|
Sell |